🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are you interested in learning more about the policy decisions affecting the lung cancer community happening in Washington? Join our Virtual Meetup on 5/20, as we welcome Brandon Leonard, LUNGevity's Senior Director of Government Affairs. Sign up now: : brnw.ch/21wSCv0

Action Alert! Congress is considering proposals that would dramatically cut Medicaid, endangering coverage for millions of people, including those living with lung cancer. Contact your legislators today and urge them to reject Medicaid cuts! bit.ly/actionalert-me…

In case you missed it, the Conversations that Count: Using a Community Health Advisors Program to Address Cancer Disparities in the Deep South webinar is now available to watch. View select portions with time stamps or watch the entire conversation here: lungevity.org/blogs/communit…

🚨 New in Journal of Clinical Oncology: LUNGevity Foundation spotlights a key barrier to #ClinicalTrials—financial toxicity. Non-medical costs like travel & lodging can block access, especially for underserved patients. 🔗 Read: ascopubs.org/doi/10.1200/JC… More: eactproject.org #CancerResearch

What gives Maggie hope? Lung cancer research! She is proof of how advancements in research help people live longer, fuller lives with lung cancer. Learn what LUNGevity is doing to protect lung cancer research and how you can help. lungevity.org/protecting-pro… What gives you hope?

Join us for a Facebook Live on 5/23, with special guest Dr. Nagla Abdel Karim (Inova Schar Cancer Institute) to discuss the application of subtyping and biomarkers for #sclc. Moderated by Misty Dawn Shields (@IU_health) & Ann Fish-Steagall (@lungevity), tune in facebook.com/lungevity @sclcsmashers #lcsm

FDA Approval Alert: U.S. FDA Approves EMRELIS™️ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression. Learn more by visiting fda.gov/drugs/resource…

Are you registered for the "Conversations That Count" webinar w/ Dr. Jeffrey Velotta? Dr. Velotta will share his work on improving #lungcancerscreening in #AsianAmericans & the rising incidence of #lungcancer in Asian American women w/ no smoking history. brnw.ch/21wSIff

Good luck to all of the #TeamLUNGevity athletes racing in the Chicago Spring Half Marathon and 10k! Thank you for racing to stop #lungcancer! Learn how you can be part of Team LUNGevity by visiting teamlungevity.org

May is Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage Month. Did you know that Asian women have a significantly higher risk of lung cancer compared to women of other ethnicities? Materials are available in 5 languages: lungevity.org/for-patients-c…

Proud to partner with PeerView on this live & virtual #CME event at #ASCO25 focused on the evolving role of immunotherapy across the NSCLC spectrum. Don’t miss it! 🗓️ May 30 | 7 PM CDT 🔗 bit.ly/2025NSCLCT #LungCancer #NSCLC #Immunotherapy

Precision lung cancer care starts with strong partnerships! Join PeerView, Oncology Brothers, Joshua Sabari, MD, gilberto lopes, and Zosia Piotrowska at #ASCO25 for Precision Matters in NSCLC! 🗓️ May 31 | ⏰ 6:30 PM CDT Reg ➡️ bit.ly/25TT-T

Dan, Augie, Ilee, Mack, Lauren, and Caitlin all have a very personal connection to lung cancer and we are honored to have them as part of Team LUNGevity racing in the Grandma’s Marathon! Learn more about Team LUNGevity by visiting teamlungevity.org #lcsm #lungcancer

What is a "Dear Colleague” letter? One of the most effective tools at a lung cancer advocate's disposal is the “Dear Colleague” letter—a powerful mechanism used in Congress to rally support for critical issues. Learn more in our latest blog: bit.ly/LUNGevity-Dear…

What gives you hope? For LUNGevity Board Member and lung cancer survivor, Barry, it’s community. Find your #lungcancer community with a virtual meetup, Facebook Group, message boards, or a LifeLine partner by visiting Lungevity.org/support #lungcancerhopemonth #lcsm

Lung cancer remains the leading cause of cancer death in the US yet it receives disproportionately less research funding. We are committed to driving progress and survivorship for everyone affected by lung cancer. Support is more critical now than ever lungevity.donorsupport.co/page/spring25

#HOPESummit25 was filled with inspirational and informative sessions that help people live well with #lungcancer. For the first time ever, select sessions were recorded for those who weren’t able to attend, and to rewatch what brnw.ch/21wSSAw #lcsm

Join us today!

Today is #NationalCancerResearchDay, and at LUNGevity, we’re proud to be the nation's largest nonprofit funder of #lungcancerresearch. Learn more about how we’re shaping the future of #lungcancer through research: lungevity.org/research #NationalCancerResearchDay